skip to Main Content
  • This page as PDF

Patient Costs Among Medicare Part D Users of Mental Health Drugs

Summary

According to a new analysis from Avalere, Medicare Part D beneficiaries who are taking mental health drugs and do not receive low-income cost-sharing support are responsible for a higher share of the cost of mental health drugs (46%) than for non-mental health drugs (23%).

As medication affordability increasingly becomes a focal point for policy makers, out-of-pocket (OOP) spending is a growing point of pressure for vulnerable populations, including those with mental health disorders. Avalere examined the burden of OOP spending on non-low-income subsidy (non-LIS) Medicare Part D beneficiaries using mental health medications.

Avalere analyzed patient progression through each phase of the Part D benefit. Among non-LIS beneficiaries taking mental health drugs of any kind during a year, 20% reached the coverage gap and 5% reached the catastrophic phase by the end of the year. Approximately half of those beneficiaries reached the coverage gap by mid-year and stayed there for an average of 4 months.

Additionally, Avalere found that beneficiaries assumed financial liability for 46% of the cost of their mental health drugs and 23% of the cost of their non-mental health drugs. This translates to an average of $760 per beneficiary in annual total OOP spending for non-LIS beneficiaries using mental health medications.

Methodology

Avalere analyzed 2018 Part D prescription drug event data as well as Medi-Span’s Generic Product Identifier therapeutic classification system to identify the following drug classes within the mental health category: antidepressants, antipsychotics, anxiolytics, and mood stabilizers. Avalere limited the analysis sample not to exceed 20% of the overall Part D beneficiary population and examined OOP costs for non-LIS Part D users of mental health drugs enrolled in non-employer group waiver plans.

To receive Avalere updates, connect with us.

Find out the top 2020 healthcare trends to watch.

From beginning to end, our team synergy
produces measurable results. Let's work together.
Back To Top